Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.98
+0.48 (3.10%)
Apr 24, 2025, 4:08 PM HKT
65.60%
Market Cap 27.87B
Revenue (ttm) 2.07B
Net Income (ttm) -1.36B
Shares Out 984.87M
EPS (ttm) -1.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,788,941
Average Volume 2,534,157
Open 16.00
Previous Close 15.50
Day's Range 15.60 - 16.26
52-Week Range 9.71 - 21.70
Beta 0.74
RSI 58.87
Earnings Date Mar 28, 2025

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 2,578
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1877
Full Company Profile

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.84% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.